Skye Bioscience Inc (SKYE)

[GM26]

I'm not sure how accurate or updated information this is, but according to Owler search Nemus Bioscience has raised $45.5M thus far into their pipeline. Nemus Bioscience has $9.5M in revenue and 2 employees. Nemus Bioscience's top competitors are GW Pharma, Cannabics Pharmaceuticals and InMed Pharmaceuticals. Nemus Bioscience's top 7 competitors are GW Pharma, Cannabics Pharmaceuticals, InMed Pharmaceuticals, STI Pharmaceuticals, Mundipharma Research, Espero Pharma and InstyMeds. Together they have raised over $78.4 Million between their estimated 554 employees.

No wonder Emerald is interested in them.